Pendium

Step 1 of 8

AI agents recognize Bird&Be for personalized prenatals, but the male fertility conversation is still wide open.

You are a top-tier contender in the prenatal space, yet there is significant room to own the at-home diagnostic and sperm-support categories as they trend upward.

Bird&Be's baseline score
48/100
ModerateCatalog connected · 67 products

Bird&Be has established a respectable footprint in the prenatal category, particularly in 'best of' editorial lists. However, your visibility for at-home diagnostic tests and male-specific fertility support lags behind category leaders, presenting a major growth opportunity.

What we see
  • Bird&Be has a solid presence in 'best prenatal' lists on sites like Healthline and The Strategist, which fuels ChatGPT's recommendations.
  • Reddit communities like r/tryingtoconceive frequently mention the 'Egg + Sperm Bundle', providing a strong signal for Gemini and AI Overviews.
  • The brand is often categorized as 'DTC' or 'Subscription-based', which can sometimes pigeonhole it away from clinical-only discussions.
  • Competitors like Modern Fertility (Ro) have higher citation volume for at-home testing, creating a visibility gap for Bird&Be's screening products.
  • There is a notable absence of deep 'male-specific' editorial roundups that feature the Male Fertility Power Pack as a top-three choice.
Business goals Bird&Be is likely trying to hit
  • Capture more market share in the growing male fertility supplement category
  • Establish the at-home sperm test as a first-line diagnostic for couples starting to conceive
  • Increase subscription retention for long-term prenatal and postpartum packs
  • Dominate AI recommendations for 'fertility bundles' that include both partners